Bioavailability Clinical Trial
Official title:
Bioavailability of Coffee Phenolic Acids and Cardiovascular Health in Healthy Humans.
Verified date | June 2018 |
Source | University of Leeds |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Phenolic acids are naturally-occurring constituents of plant-derived foods and beverages and
are characterised by a phenol ring in their structure. The phenolic compounds we are going to
focus on in this study are the Chlorogenic acids (CGAs), a family of esters conjugates formed
between a Hydroxycinnamic acid and quinic acid (1) and that show a strong antioxidant
activity (2).
HCAs represent about 50% of the total polyphenolic coumpounds intake in a typical UK diet (3)
and for people who drink it, coffee is a/the major dietary source of/for HCAs (4). A few
studies suggest protective effects for cardiovascular diseases (5), neurodegenerative
diseases, type 2 diabetis and liver and kidneys cancer risk. However, many data in the field
are obtained from in vitro and/or in animal, and it is difficult and dangerous to extrapolate
between these and risk in humans of development or progression of particular health
conditions, more human studies are therefore needed.
We aim to compare people that metabolise the best CGAs from coffee to those that metabolise
them the least well. This will be achieved by measuring the metabolites in urine. The effect
of CGAs on the human body does not only depend on the amount ingested, but also on the
quality of the metabolism, we therefore also want to determine which mechanisms are
responsible for inter-individual variations in order to identify any link with health
biomarkers, these including non-cellular inflammation and cardiovascular risk indicators.
For this cohort study funded by the University of Leeds, approximately 60 healthy volunteers
will be recruited at the School of Food Science & Nutrition. If they meet the selection
criteria, participants will be asked to undergo a 36-hour wash-out period. During those 36
hours, participants won't be allowed to drink coffee, they will be asked to follow a diet low
in phenolic acids and keep a record of their meals. On the first day of the study, a single
dose of coffee rich in antioxidants will be given to the participant and urine will be
collected from that time until 36 hours after coffee consumption. Participants will be
followed again after 5 to 6 weeks.
Status | Completed |
Enrollment | 62 |
Est. completion date | June 27, 2018 |
Est. primary completion date | November 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Age 18-70 years - Normal Body Mass Index (BMI) 18-29 kg/m2 - Non-smoker, former or weak smoker (max. 5 cigarettes per day) - No more than 4 alcoholic units as a regular and daily consumption Exclusion Criteria: - diagnosed chronic disease (e.g. pancreas, kidneys, liver, heart) - haemophilia - long term prescribed medication (contraceptive medication allowed) - previous GI (gastrointestinal) tract operation - pregnant or breast feeding |
Country | Name | City | State |
---|---|---|---|
United Kingdom | School of Food Science, University of Leeds | Leeds | West Yorkshire |
Lead Sponsor | Collaborator |
---|---|
University of Leeds |
United Kingdom,
D'Archivio M, Filesi C, Di Benedetto R, Gargiulo R, Giovannini C, Masella R. Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita. 2007;43(4):348-61. Review. — View Citation
M.N. Clifford, J. Sci. Food Agric. 80 (2000) 1033-1043.] [Clifford MN, Chlorogenic acids and other cinnamates-nature, occurrence and dietary burden. Journal of the Science of Food and Agriculture 1999, 79(3), 362-372
Stalmach et al. 2006, On-line HPLC analysis of the antioxidant activity of phenolic compounds in brewed paper-filtered coffee. Brasil J Plant Physiol 18:253-262
Stanner 2005, Cardiovascular disease: Diet, Nutrition and emerging risk factors. The report of the british nutrition foundation task force. Blackwell Science for the British nutrition foundation: Oxford, UK
Stevenson DE, Hurst RD. Polyphenolic phytochemicals--just antioxidants or much more? Cell Mol Life Sci. 2007 Nov;64(22):2900-16. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Quantitative absorption of chlorogenic acids metabolites | Analysis using liquid chromatography with or without mass spectrometry, colorimetric and enzyme-linked immunosorbent assays. | up to 7 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06043739 -
Relative Bioavailability and Effect of Food Study With an Oral Mini-tablet Formulation of Filgotinib in Healthy Subjects
|
Phase 1 | |
Completed |
NCT02557139 -
Bioavailability of Belumosudil (KD025) in Healthy Male Subjects
|
Phase 1 | |
Completed |
NCT02010944 -
A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels
|
Phase 1 | |
Completed |
NCT01208155 -
Study in Healthy Males to Assess Bioavailability of 4 Different Fostamatinib Tablets
|
Phase 1 | |
Not yet recruiting |
NCT01136551 -
Comparative Bioavailability Study of an Immediate Release and Controlled Release Oral Formulations of Huperzine A
|
N/A | |
Completed |
NCT04097808 -
Impact of the Source and Food Matrices on the Bioavailability of Peptan® (Collagen Peptides) in Healthy Subjects
|
N/A | |
Active, not recruiting |
NCT06098001 -
Bioavailability Study of Hemp Phenolics
|
N/A | |
Completed |
NCT03915626 -
Effect of Heat on Rivastigmine TDS Products
|
Early Phase 1 | |
Completed |
NCT01464450 -
Pharmacokinetics Study of Oral Rivaroxaban in Healthy Participants
|
Phase 1 | |
Completed |
NCT01448772 -
Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT01181973 -
Safety, Tolerability and Relative Bioavailability of Pegvisomant in Healthy Subjects
|
Phase 1 | |
Completed |
NCT00858767 -
Arabic Gum-Absorption Study
|
N/A | |
Completed |
NCT04113564 -
Absolute Oral Bioavailability of Remimazolam
|
Phase 1 | |
Completed |
NCT04645394 -
Bioavailability of Anthocyanins From Aronia Extract in Healthy Men - a Pilot Study
|
N/A | |
Completed |
NCT03485885 -
Bioavailability of Maqui Berry Extract (MBE) in Healthy Subjects
|
||
Completed |
NCT05840848 -
Effect of Iron and Zinc Supplementation on B-carotene Bioavailability in Healthy Males
|
N/A | |
Completed |
NCT02986529 -
A Study to Assess the Bioavailability of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Male Subjects
|
Phase 1 | |
Completed |
NCT01789359 -
Urinary Excretion of Anthocyanins During Long Term Blueberry Feeding
|
N/A | |
Completed |
NCT01638143 -
Bio-equivalence Study
|
N/A | |
Completed |
NCT00755872 -
Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of Risedronate
|
Phase 1 |